Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
- 31 October 1991
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 325 (18), 1274-1277
- https://doi.org/10.1056/nejm199110313251803
Abstract
In early 1990 fluconazole was introduced as a prophylactic antifungal agent after bone marrow transplantation. During the same year Candida krusei emerged as the chief candida pathogen among patients with bone marrow transplants.Keywords
This publication has 13 references indexed in Scilit:
- Failure of Fluconazole to Suppress Fungemia in a Patient with Fever, Neutropenia, and TyphlitisThe Journal of Infectious Diseases, 1991
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989
- Fungemia Caused by Candida Species and Torulopsis glabrata in the Hospitalized Patient: Frequency, Characteristics, and Evaluation of Factors Influencing OutcomeClinical Infectious Diseases, 1989
- Nosocomial fungemia in a large community teaching hospitalArchives of Internal Medicine, 1987
- Role of Fibronectin in the Pathogenesis of Candidal InfectionsClinical Infectious Diseases, 1987
- Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of TherapyClinical Infectious Diseases, 1985
- The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal InfectionsThe Journal of Infectious Diseases, 1980
- Incidence of polyene-resistant yeasts recovered from clinical specimensAntimicrobial Agents and Chemotherapy, 1980
- Torulopsis glabrata infections in patients with cancer: Increasing incidence and relationship to colonizationThe American Journal of Medicine, 1976